Tags

Type your tag names separated by a space and hit enter

A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia.
Addiction. 2009 Sep; 104(9):1541-8.A

Abstract

AIMS

To describe all people dying from unintentional overdoses of methadone or other opioid analgesics (OOA) in West Virginia in 2006.

DESIGN

We analyzed medical examiner data supplemented by data from the state prescription drug monitoring program. We compared people whose deaths involved methadone with those whose deaths involved OOA.

FINDINGS

The methadone group included 87 decedents, and the OOA group included 163 decedents. Most were male. Decedents in the methadone group were significantly younger than those in the OOA group: more than a quarter were 18-24 years of age. For both groups, approximately 50% had a history of pain, and 80% had a history of substance abuse. There was no intergroup difference in the prevalence of benzodiazepines at post-mortem. Methadone was significantly less likely to have ever been prescribed than OOA. Among those with prescriptions, the proportion prescribed within 30 days of death was significantly greater for methadone than for hydrocodone, but not for oxycodone. Ten (11.5%) of the methadone decedents were enrolled in an opiate treatment program (OTP) at the time of death.

CONCLUSIONS

The high prevalence of a substance abuse history and lack of prescriptions suggest that most of the deaths in both groups are related to substance abuse. There was no indication of a harmful effect from methadone's metabolic interaction with benzodiazepines, but provider or patient unfamiliarity with methadone may have been a risk factor. Prescribing methadone, especially to young males, requires extra care. Providers, OTPs and coroners/medical examiners should use state prescription drug monitoring programs to monitor the use of controlled substances by their patients.

Authors+Show Affiliations

National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, 4770 Buford Highway NE, Mailstop F-62, Atlanta, GA 30341-3717, USA. lbp4@cdc.govNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

19686524

Citation

Paulozzi, Leonard J., et al. "A Comparison of Drug Overdose Deaths Involving Methadone and Other Opioid Analgesics in West Virginia." Addiction (Abingdon, England), vol. 104, no. 9, 2009, pp. 1541-8.
Paulozzi LJ, Logan JE, Hall AJ, et al. A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia. Addiction. 2009;104(9):1541-8.
Paulozzi, L. J., Logan, J. E., Hall, A. J., McKinstry, E., Kaplan, J. A., & Crosby, A. E. (2009). A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia. Addiction (Abingdon, England), 104(9), 1541-8. https://doi.org/10.1111/j.1360-0443.2009.02650.x
Paulozzi LJ, et al. A Comparison of Drug Overdose Deaths Involving Methadone and Other Opioid Analgesics in West Virginia. Addiction. 2009;104(9):1541-8. PubMed PMID: 19686524.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia. AU - Paulozzi,Leonard J, AU - Logan,Joseph E, AU - Hall,Aron J, AU - McKinstry,Edna, AU - Kaplan,James A, AU - Crosby,Alexander E, PY - 2009/8/19/entrez PY - 2009/8/19/pubmed PY - 2010/2/2/medline SP - 1541 EP - 8 JF - Addiction (Abingdon, England) JO - Addiction VL - 104 IS - 9 N2 - AIMS: To describe all people dying from unintentional overdoses of methadone or other opioid analgesics (OOA) in West Virginia in 2006. DESIGN: We analyzed medical examiner data supplemented by data from the state prescription drug monitoring program. We compared people whose deaths involved methadone with those whose deaths involved OOA. FINDINGS: The methadone group included 87 decedents, and the OOA group included 163 decedents. Most were male. Decedents in the methadone group were significantly younger than those in the OOA group: more than a quarter were 18-24 years of age. For both groups, approximately 50% had a history of pain, and 80% had a history of substance abuse. There was no intergroup difference in the prevalence of benzodiazepines at post-mortem. Methadone was significantly less likely to have ever been prescribed than OOA. Among those with prescriptions, the proportion prescribed within 30 days of death was significantly greater for methadone than for hydrocodone, but not for oxycodone. Ten (11.5%) of the methadone decedents were enrolled in an opiate treatment program (OTP) at the time of death. CONCLUSIONS: The high prevalence of a substance abuse history and lack of prescriptions suggest that most of the deaths in both groups are related to substance abuse. There was no indication of a harmful effect from methadone's metabolic interaction with benzodiazepines, but provider or patient unfamiliarity with methadone may have been a risk factor. Prescribing methadone, especially to young males, requires extra care. Providers, OTPs and coroners/medical examiners should use state prescription drug monitoring programs to monitor the use of controlled substances by their patients. SN - 1360-0443 UR - https://www.unboundmedicine.com/medline/citation/19686524/A_comparison_of_drug_overdose_deaths_involving_methadone_and_other_opioid_analgesics_in_West_Virginia_ L2 - https://doi.org/10.1111/j.1360-0443.2009.02650.x DB - PRIME DP - Unbound Medicine ER -